AMSC Stock Analysis: American Superconductor | NASDAQ
Specialty Industrial Machinery | NASDAQ, USA | Market Cap: 1.798m USD | 12M Return: -7.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 42.2M
Qual. Beats: 0
Rev. Trend: 99.5%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
American Superconductor Corporation (AMSC) provides megawatt-scale power resiliency solutions through two segments: Grid and Wind. The Grid segment, branded Gridtec Solutions, supplies products and services to electric utilities, industrial facilities, and renewable energy developers, including transmission planning, grid interconnection systems for wind and solar projects, power quality systems, and reactive compensation products such as D-VAR, actiVAR, and armorVAR. This segment also produces ship protection systems, propulsion motors, transformers, and rectifiers.
The Wind segment, marketed as Windtec Solutions, designs wind turbine drivetrains with power ratings of 2 MW and higher and licenses these designs to third-party manufacturers. It additionally supplies power electronics, software-based control systems, and support services to wind turbine makers.
Founded in 1987 and headquartered in Ayer, Massachusetts, AMSC operates in the electrical components and equipment industry. Its licensing-based wind turbine model generates revenue without the capital intensity of full turbine manufacturing, while the Grid segment addresses rising utility demand for voltage stability and power quality solutions tied to the integration of renewable generation.
- Grid segment revenue grows on utility renewable energy demand
- Wind turbine design licensing tied to global wind project pipeline
- Navy ship protection system awards expand defense revenue base
| Net Income: 133.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.86 > 1.0 |
| NWC/Revenue: 64.59% < 20% (prev 47.91%; Δ 16.68% < -1%) |
| CFO/TA 0.03 > 3% & CFO 23.1m > Net Income 133.8m |
| Net Debt (-129.3m) to EBITDA (24.1m): -5.38 < 3 |
| Current Ratio: 2.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.7m) vs 12m ago 21.33% < -2% |
| Gross Margin: 30.15% > 18% (prev 27.76%; Δ 2.39% > 0.5%) |
| Asset Turnover: 56.98% > 50% (prev 71.76%; Δ -14.77% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.26 (Total Current Assets 331.7m - Total Current Liabilities 138.5m) / Total Assets 739.5m |
| B: -1.25 (Retained Earnings -926.8m / Total Assets 739.5m) |
| C: 0.03 (EBIT TTM 16.0m / Avg Total Assets 525.0m) |
| D: 3.02 (Book Value of Equity 555.4m / Total Liabilities 184.0m) |
| Altman-Z'' = 1.00 = BB |
| DSRI: 1.12 (Receivables 69.4m/46.2m, Revenue 299.2m/222.8m) |
| GMI: 0.92 (GM 27.76% / 30.15%) |
| AQI: 2.14 (AQ_t 0.42 / AQ_t-1 0.20) |
| SGI: 1.34 (Revenue 299.2m / 222.8m) |
| TATA: 0.15 (NI 133.8m - CFO 23.1m) / TA 739.5m) |
| Beneish M = -2.06 (Cap -4..+1) = BB |
As of July 09, 2026, the stock is trading at USD 36.00 with a total of 828,820 shares traded. Over the past week, the price has changed by -13.27%, over one month by -16.94%, over three months by +9.02% and over the past year by -7.53%.
Current recommended Stop Loss: 30.00 (which is 16.7% or 1.9 ATR below the current price).
American Superconductor has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy AMSC.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 65.3 | 81.5% |
P/E Trailing = 12.1672
P/E Forward = 35.8423
P/S = 6.0117
P/B = 3.2387
P/EG = 0.7414
Revenue TTM = 299.2m USD
EBIT TTM = 16.0m USD
EBITDA TTM = 24.1m USD
Long Term Debt = 6.12m USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.24m USD (from shortTermDebt, last quarter)
Debt = 11.4m USD (corrected: LT Debt 6.12m + ST Debt 1.24m) + Leases 4.00m
Net Debt = -129.3m USD (calculated: Debt 11.4m - CCE 140.7m)
Enterprise Value = 1.67b USD (1.80b + Debt 11.4m - CCE 140.7m)
Interest Coverage Ratio = unknown (Ebit TTM 16.0m / Interest Expense TTM 0.0)
EV/FCF = 91.41x (Enterprise Value 1.67b / FCF TTM 18.3m)
FCF Yield = 1.09% (FCF TTM 18.3m / Enterprise Value 1.67b)
FCF Margin = 6.10% (FCF TTM 18.3m / Revenue TTM 299.2m)
Net Margin = 44.73% (Net Income TTM 133.8m / Revenue TTM 299.2m)
Gross Margin = 30.15% ((Revenue TTM 299.2m - Cost of Revenue TTM 209.0m) / Revenue TTM)
Gross Margin QoQ = 25.94% (prev 30.66%)
Tobins Q-Ratio = 2.26 (Enterprise Value 1.67b / Total Assets 739.5m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 11.4m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 12.6m (EBIT 16.0m * (1 - 21.00%))
Current Ratio = 2.39 (Total Current Assets 331.7m / Total Current Liabilities 138.5m)
Debt / Equity = 0.02 (Debt 11.4m / totalStockholderEquity, last quarter 555.4m)
Debt / EBITDA = -5.38 (Net Debt -129.3m / EBITDA 24.1m)
Debt / FCF = -7.08 (Net Debt -129.3m / FCF TTM 18.3m)
Total Stockholder Equity = 441.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 25.49% (Net Income 133.8m / Total Assets 739.5m)
RoE = 30.28% (Net Income TTM 133.8m / Total Stockholder Equity 441.9m)
RoCE = 3.56% (EBIT 16.0m / Capital Employed (Equity 441.9m + L.T.Debt 6.12m))
RoIC = 2.15% (NOPAT 12.6m / Invested Capital 587.2m)
WACC = 17.10% (E(1.80b)/V(1.81b) * Re(17.21%) + D(11.4m)/V(1.81b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 17.21% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 100.00 | Cagr: 23.45%
[DCF] Terminal Value 47.57% ; FCFF base≈21.3m ; Y1≈18.7m ; Y5≈15.1m
[DCF] Fair Price = 4.76 (EV 101.2m - Net Debt -129.3m = Equity 230.5m / Shares 48.5m; r=17.10% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.23 | # QB: 0
Revenue Correlation: 99.49 | Revenue CAGR: 45.88% | SUE: 1.67 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.21 | Chg30d=-12.04% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.23 | Chg30d=-4.78% | Revisions=+0% | Analysts=3
EPS current Year (2027-03-31): EPS=1.05 | Chg30d=-0.95% | Revisions=-17% | GrowthEPS=-70.9% | GrowthRev=+20.4%
EPS next Year (2028-03-31): EPS=1.48 | Chg30d=+7.23% | Revisions=+50% | GrowthEPS=+41.7% | GrowthRev=+16.0%
[Analyst] Revisions Ratio: +15% (up=6, down=4)